Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm in the process of selling my position - fed up - turned out to be the most horrible "investment decision" I've made
Pay for performance. The management team have not delivered shareholder value, they've devastated it. It's a tiny company - 200. Looking at both of these the comps to other companies just don't work. They are massively over paid. The Board has a comp committee and they have no credit IMO either.
brilliant
Really?! For a 200 employee company? For this stock performance?
King: $946K
Lytle $648K
Ziebell: $500K
Fussey: $455
Shan: $397K
This is one question I'd be asking / addressing if I were a board member or majority share holder
Just looked at how senior management are compensated and it's ridiculous IMO - WAY over compensated for the size of the operation and stock performance.
a boom? A splat yes when the reverse split comes! Perhaps months out, but what's the catalyst now? A long shot cash injection from a partnership that's been talked about for years now with nothing to show for it
I was very disappointed not to hear any cost cutting measures or statement about renewed / aggressive partnership focus
Was this case ever resolved or is it still ongoing?
thanks, but doesn't look material. Feels like traders will move this up and down in the current range (interesting battle on the moving average right now), with perhaps some news about the phase 2/3 BC trial starting imminently producing a short term ripple...
...off to walk my dog here early morning in Solana Beach, CA
Have a good day - go Sunrise
"50K went off at 1.17."
What does that mean/indicate?
yes, they've overcome a lot of hurdles since, and I feel good about the future. It's been longer than I anticipated to reap the reward of my investment, but given my $0.75 average and the much longer time many others here have been waiting, I can't really complain. It's all about sunrise now, and I can wait another year with everything crossed
it was the headline crash - now 3 years ago? - of PPHM that caught my attention that got me into the stock. Been waiting for it to recover and some since...
I'm assuming full enrollment will get formally announced when achieved...
wonder if they'll announce full enrollment at one of the conferences in December...
Loofman's Sobered-up Share Price Reality Check!
... 12/31/15 = $2.36 -- 6/30/16 = $3.66
wish I could remember what data set it was in the two and a half years I've been here, but I recall some here on this board crowing about how the data must be terrific for one event because we hadn't heard any results yet - the "simulation" being based on the assumption that the longer it took for us to hear something the better the result must be - i.e., patients living longer. Turned out when the actual data came out the data was blah and all the "simulators" were perplexed / astounded. I've learned to take these simulations now with a healthy pinch of salt and personally, I'm just going to sit back, keep everything crossed, and wait for events to unfold.
yep - that's what I'm hoping - they are close to a partnership to the extent they are messaging new planned trials
yeah - this and also the plans for new trials - seems like that must be related to some partnership - otherwise why mention the plans if they can't afford to execute the trials?
<<until they provide a solution to the dilution gravity pull, the rocket ship is stuck on planet PPHM....>>
well said
ClayTrader said $1.39 is a support level and need to hold to maintain the recent up trend
New planned trials sound expensive - hopefully being developed in partnership?
Roche's atezolizumab (antiPDL1) shrank tumours in two thirds of people with the most common type of lung cancer when combined with chemo in a Phase 1b study - just announced.
3 phase III studies of atezolizumab in conbo with chemo in 1L NSCLC have been initiated
Are we at the stage of judge making his ruling yet? When is the due date for this? Or are we still at material gathering/submissions?
neck collar - that was funny
no shortage of buying ops here...
...and still nothing to show for it 8 months later - yikes
yes - I agree - even PPHM management have stopped saying partnership discussions in CC's
ok good - thanks. So trial formally scheduled for June? I'm wondering if this [settlement/resolution] is a material hurdle for any partnership?
if only I had a dollar for every time I've read "partnership imminent" on this board over the last 2+ years...definitely is more likely than ever given whats been achieved with getting Sunrise going...but at present this type of statement has had no credibility to date along with all the other fanciful predictions that get tossed around here - "$2 by Friday" [and that was weeks ago] is one recent example I recall during the pump & dump.
is there a defined date for the judgement?
whats the schedule for a ruling on this matter?
yep - I too am a value investor and was all over this like a rash after the "unfortunate" for most, but fortunate for me, news regarding the phase II results and was buying with everything I had at $0.70 - $0.80 after a weekend of intensive DD, so I'm sitting with a great risk/reward profile for me. It is taking longer than I anticipated to get above $2 and onwards - [not so] patiently waiting...
yeah - I was pretty convinced that spike above $2 was a sign of something material coming. Maybe it was and discussions fell through for some reason - that's my guess.
In my 2 1/2 yrs experience in [and watching] this stock, it's my opinion that it's better to take and build a position at a price and risk/reward profile you are comfortable with, plugging in whatever variables you value into your decision algorithm, rather than jumping on momentum that has proven to be transitory these last two years - last week being a perfect example. At some stage I hope this advice/rule will be proven wrong if/when a material event is surfacing, but to date this not happened and are therefore rare - another variable to consider in risk/reward assessment. IMO I'd consider a break above $2 and ongoing upward momentum to be significant and a signal of something really brewing. In the long run your purchases will hopefully pay off anyway, even if bought in the near term at a premium to current average market value. Good luck to you.
huh? I didn't sell anything.
This week's dump was quite impressive after last week's pump. So much for "$2 by Friday".
Piper sticking to $4 PT with updated report published today...
...JMP Securities dropped their coverage of PPHM Dec 2014 due to the analyst leaving...
...and I've never been able to read a report from mlv or roth...
The only coverage I see is from Piper - and no, no update yet. PT of $4 for a while now.
That was actually a pretty decent CC today